CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 75.2% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.

Close

Trade Novavax NVAX

Novavax live chart

Instrument Fundamentals

Weekly Search
Weekly
Daily
Date Close Change Change (%) Open High Low

Novavax news

Emma Rose 2025 Jul 03, 08:35

US Economy on Stagflation Watch: Apollo Global Management's Outlook

Ava Grace 2025 Jul 03, 08:35

AI Podcast: Fresh Insights on Fed Rate Cut Timing - News in a New Way

Sophia Claire 2025 Jul 03, 07:35

S&P 500 Earnings Season to Test Rally Amidst Dim Outlook

2021 May 11, 13:20

US pre-market: selling unabated

2021 May 06, 08:27

Stocks rally as Fed speakers get back on script, earnings support + Bank of England set to raise forecasts

2021 Feb 28, 07:36

Week Ahead: RBA speaks, US NFPs released & OPEC clash

2020 May 26, 08:04

Leg up: stocks make new ground, travel stocks soar

Latest news

Show more
Sophia Claire 2025 Jul 14, 13:20

Trump Admin Leverages Fed Renovation for Powell Ouster Amid Rate Dispute

Emma Rose 2025 Jul 14, 13:20

Pound Sterling Outlook: Interest Rates and Economic Indicators in Focus

Sophia Claire 2025 Jul 14, 09:20

Trump's Tariff Threat Looms: Will It Trigger EU Recession and Force ECB Rate Cuts?

Noah Lee 2025 Jul 14, 08:23

Federal Reserve Renovation Project: Defending Costs and Features

Emma Rose 2025 Jul 14, 08:23

Musk Joins Calls for 'Epstein List' Release as Trump Urges MAGA Unity

Frances Wang 2025 Jul 13, 16:00

Crypto News Today: Bitcoin Price (BTC-USD) Is over $119K

Cryptocurrencies
Tommy Yap 2025 Jul 13, 16:00

Morning Note: Gold Gains on Tariffs; Trump Targets EU/Mex; Japan Poll

Morning Note Central Banks Forex
Tommy Yap 2025 Jul 12, 21:00

 Week Ahead: Inflation Data from U.S., Canada, and U.K. Take Centre Stage

Forex Indices

Info

Spread

0.05

Spread (%)

0.7246 %

Leverage

1:5

Overnight Interest Buy

-0.0597 %

Overnight Interest Sell

-0.0292 %

Currency

USD

Trading Hours

Markets closed

Monday

13:31 - 19:59

Tuesday

13:31-19:59

Wednesday

13:31-19:59

Thursday

13:31-19:59

Friday

13:31-19:59

Analysis and statistics

Open

---

Previous Close

---

52 Week High/Low

--- – ---

Market cap

1107874816

Shares Outstanding

161970000

Earnings Date (Next)

2019-05-10

Div Yield

2019-05-10

Ex-Dividend Date

Forward annual dividend rate

0

Forward annual dividend yield

0

EPS

2.75

Learn more about this instrument

Novavax Novavax Inc
Novavax, Inc., a biotechnology company, engages in the discovering, developing, and commercializing vaccines to protect against serious infectious diseases in the United States, Europe, and internationally. The company offers vaccine platform that combines a recombinant protein approach, nanoparticle technology, and its patented Matrix-M adjuvant to enhance the immune response. The company is commercializing a COVID-19 vaccine, NVX-CoV2373 under the brand names of Nuvaxovid, Covovax, and Novavax COVID-19 Vaccine, adjuvanted for adult and adolescent populations as a primary series and for both homologous and heterologous booster indications. It also developing R21/Matrix-M adjuvant malaria vaccine. Novavax, Inc. was incorporated in 1987 and is headquartered in Gaithersburg, Maryland.

Related Instruments

Asset
Sell
Buy
Change (%)
View all instruments

Latest Education Articles

Show more
Markets.com Support Team 2025 Jul 13, 21:00

Crypto 2025: Exploring the Trends and How It’s Shaping Trading Behavior

Crypto
Ghko B 2025 Jul 13, 16:00

BA Stock Is Rising Now: Is Boeing Company Stock (BA) a Buy Now?

Stocks
Frances Wang 2025 Jul 13, 16:00

CFD Trading Terminology: CFD Trading Terms for Beginners to Understand

CFD Trading
Trustpilot